“…Here, we will discuss inteins as potential targets to selectively kill bacterial and fungal pathogens, along with the screening assays that could be used to test the ability of small molecules to inhibit protein splicing. There is proof of concept evidence that divalent cations (in particular zinc and copper), reactive oxygen, nitrogen, and chlorine derivatives, as well as small molecules including cisplatin and diethanolamine can act as splicing inhibitors and impact the fitness of pathogenic mycobacteria and fungi (Gangopadhyay et al, 2003;Zhang et al, 2010;Zhang et al, 2011;Dasari et al, 2015;Topilina et al, 2015a;Kelley et al, 2018;Li et al, 2019;Lennon et al, 2021;Panda et al, 2021) The discovery of drug-like molecules that can successfully inhibit the splicing of proteins essential for survival of pathogens could represent new treatment options. Because inteins are absent in humans, specific intein inhibitors could have limited side effects.…”